Aframomum citratum
Aframomum citratum · Accepted scientific name
Scientific literature: Very Sparse (3 studies) · ★☆☆☆☆
Aframomum citratum is a versatile botanical species recognized for its significant antioxidant and antibacterial activities. The plant contains a rich profile of bioactive compounds, including chlorogenic acid, flavonoids, and pimaric acid. Research suggests that its chemical constituents may play a role in managing obesity and addressing diabetes complications by modulating inflammatory markers like IL-6 and IL-8. Various forms of the plant are studied for therapeutic potential, ranging from simple extracts to specialized spice extracts. Furthermore, scientists frequently utilize hydro-alcoholic and methanol extracts to isolate its most potent medicinal properties.
- Synonyms
- Amomum Macrolepis · Cardamomum Citratum · 1 more
- Common names
- Not available
- Family
- Zingiberaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Synonyms
Aframomum citratum is a botanical species that is frequently identified by several different scientific names in various texts. It is widely recognized as having the synonym Amomum citratum, which can sometimes lead to confusion in taxonomic records. Additionally, the plant is also referred to as Amomum macrolepis depending on the specific botanical classification used. Some researchers and historical documents may even list it under the name Cardamomum citratum. Understanding these various synonyms is essential for accurately identifying the plant across different scientific databases.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Aframomum citratum is a distinctive member of the kingdom Plantae. Within this vast biological realm, it belongs to the class Equisetopsida. It is further classified under the order Zingiberales, which highlights its unique evolutionary lineage. This plant is a notable representative of the genus Aframomum. Ultimately, its botanical identity is defined by its placement within the Zingiberaceae family.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Zingiberales |
| Family | Zingiberaceae |
| Genus | Aframomum |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Aframomum citratum is a plant species primarily distributed across the diverse landscapes of the African continent. Its presence is notably established within the tropical regions of West Africa, specifically throughout Nigeria. The species also extends its reach into West-Central Tropical Africa, flourishing in the environments of Cameroon and Equatorial Guinea. Furthermore, its natural habitat encompasses the lush terrains of Gabon, highlighting its regional importance. This distribution pattern underscores the plant's significant ecological footprint within the West and West-Central tropical zones.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Aframomum citratum is a self-supporting herb characterized by its distinctive growth form. This plant typically reaches a maximum height of 2 meters during its development. However, under optimal conditions, it can occasionally grow to reach a height of up to 3.048037064 meters. This variation in stature highlights the plant's ability to adapt to its specific environment.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Aframomum citratum is a Cameroonian spice that demonstrates significant biological potential through its diverse therapeutic properties. Research indicates that this plant possesses notable antioxidant activity, effectively reducing reactive oxygen species in cell-free systems and gastric epithelial cells. Furthermore, the plant exhibits potent antibacterial activities against a wide panel of Gram-negative bacteria. This includes effectiveness against multidrug-resistant phenotypes, making it a subject of interest for combating modern bacterial infections. Together, these findings highlight the medicinal value of Aframomum citratum in both managing oxidative stress and treating microbial threats.
Compounds
Aframomum citratum is a Cameroonian spice that demonstrates significant potential in managing cardio-metabolic diseases. Chemical analysis through GC-MS has revealed that this plant contains key secondary metabolites, including chlorogenic acid and pimaric acid. These specific compounds are believed to justify the biological properties observed during experimental screening. Specifically, the plant shows a strong and selective activity against pancreatic lipase, which is highly relevant to treating obesity. Such findings suggest that extracts from Aframomum citratum could be developed into effective nutraceuticals for managing metabolic complications.
Conditions
Aframomum citratum demonstrates significant therapeutic potential by treating several pro-inflammatory mediators, specifically reducing the expression of IL-6 and IL-8. The plant extract also effectively treats PTGS2 (COX-2) without affecting PTGS1 (COX-1) in gastric cells. Furthermore, it acts to treat TNFα-induced NF-κB driven transcription to decrease overall inflammatory markers. Beyond its anti-inflammatory properties, Aframomum citratum is also effective in treating multidrug-resistant (MDR) bacteria. These combined biological activities support the traditional medicinal use of this Cameroonian spice.
Preparations
Aframomum citratum is prepared as extracts to investigate various biological activities and medicinal properties. These specific spice extracts are utilized in studies to evaluate their effects on cardio-metabolic enzymes and antioxidant capacities. Furthermore, the plant is prepared as hydro-alcoholic extracts to examine its potential anti-inflammatory activities within gastric epithelial cells. Researchers also utilize Aframomum citratum when it is prepared as methanol extracts to test its antibacterial effectiveness against multidrug-resistant bacteria. Through these different preparation methods, the plant's secondary metabolites are analyzed for their therapeutic potential.